Respiratory Medicine

Top Story

Tezepelumab lowers asthma exacerbations vs. placebo

September 6, 2017

Read the Perspective from Michael Blaiss, MD

When compared with placebo, tezepelumab lowered clinically significant asthma exacerbations in adults with long-acting beta-agonists and medium-to-high doses of inhaled glucocorticoids, regardless of blood eosinophil counts at trial onset.

The results of the phase 2 trial were published recently in the New England Journal of Medicine.

In the Journals

White children twice as likely to receive unnecessary antibiotics in ED

September 5, 2017
Compared with Hispanic or black children, white children were nearly twice as likely to receive antibiotics in the ED for the treatment of viral acute respiratory tract
In the Journals Plus

Lower respiratory tract infections remain leading infectious cause of death worldwide

August 30, 2017
Lower respiratory infections accounted for 2.74 million deaths in 2015, making them the fifth leading cause of death and leading infectious cause of death worldwide…
In the Journals

COPD, asthma cited as important contributors to disease burden worldwide

August 25, 2017
In 2015, chronic obstructive pulmonary disease contributed to 3.2 million deaths worldwide and asthma contributed to 0.4 million deaths. These statistics demonstrate…
More Headlines »
CME Video

Advances in Ulcerative Colitis Management: Targeting Inflammation to Achieve Remission Across the Disease Spectrum

This activity is supported by an educational grant from Salix, A Dvision of Valeant Pharmaceuticals North America, LLC.

Although ulcerative colitis (UC) is globally one of the most common inflammatory bowel diseases, many patients continue…
More »
GI Bookshelf

Chapter 50: Gastrointestinal Complications Of Bariatric Surgery

From Clinical Nutrition in Gastrointestinal Disease
More »
Resource Centers
American Association of Nurse Practitioners National Conference

American Association of Nurse Practitioners National Conference

Video
Meeting News Coverage

VIDEO: Leone: FDA regulating e-cigarettes reduces ‘potential for harm;’ ACP applauds decision

May 7, 2016
More »
Advertisement
Advertisement